Bionik Laboratories Corp.
BNKL
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.81M | 1.50M | 1.10M | 845.30K | 1.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.81M | 1.50M | 1.10M | 845.30K | 1.27M |
| Cost of Revenue | 815.30K | 626.90K | 372.80K | 265.10K | 320.40K |
| Gross Profit | 989.90K | 868.40K | 730.70K | 580.10K | 953.30K |
| SG&A Expenses | 4.86M | 4.74M | 4.81M | 4.73M | 4.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.58M | 6.42M | 6.52M | 6.19M | 6.05M |
| Operating Income | -4.77M | -4.93M | -5.41M | -5.34M | -4.77M |
| Income Before Tax | -4.95M | -5.29M | -11.20M | -11.34M | -10.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.95 | -5.29 | -11.20 | -11.34 | -10.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.95M | -5.29M | -11.20M | -11.34M | -10.41M |
| EBIT | -4.77M | -4.93M | -5.41M | -5.34M | -4.77M |
| EBITDA | -4.71M | -4.87M | -5.35M | -5.26M | -4.67M |
| EPS Basic | -0.72 | -0.81 | -1.84 | -1.89 | -1.77 |
| Normalized Basic EPS | -0.44 | -0.51 | -0.60 | -0.63 | -0.61 |
| EPS Diluted | -0.72 | -0.81 | -1.84 | -1.89 | -1.77 |
| Normalized Diluted EPS | -0.44 | -0.51 | -0.60 | -0.63 | -0.61 |
| Average Basic Shares Outstanding | 27.61M | 26.49M | 25.52M | 24.49M | 23.31M |
| Average Diluted Shares Outstanding | 27.61M | 26.49M | 25.52M | 24.49M | 23.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
